Komori
Denso (6902) · InitiativeFirst stated

Commercialization of Novel Coronavirus Testing Equipment and Biosensors

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Commercialization of Novel Coronavirus Testing Equipment and BiosensorsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「学校法人東海大学, 国立大学法人豊橋技術科学大学, 学校法人中部大学, and the company have been developing COVID-19 testing equipment with support from the Japan Agency for Medical Research and Development. In August 2021, they announced that they had developed a biosensor using a new mechanism and successfully detected the novel coronavirus. They will accelerate development toward commercialization with the aim of contributing to the early diagnosis of infectious diseases.」

    The company has disclosed for the first time an initiative that successfully detected the novel coronavirus through joint development with universities and research institutions and is moving toward commercialization for the early diagnosis of infectious diseases.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Denso's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Commercialization of Novel Coronavirus Testing Equipment and Biosensors | DENSO CORPORATION (6902) | Komori